Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment

Alparslan Merdin,Dicle İskender,Bahar Uncu Ulu,Mehmet Dogan,Merih Kızıl Çakar,Mehmet Sinan Dal,Fevzi Altuntas

Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment

2019

Alparslan Merdin
Dicle İskender
Bahar Uncu Ulu
Mehmet Dogan
Merih Kızıl Çakar
Mehmet Sinan Dal
Fevzi Altuntas

AbstractRationale:Relapsed or refractory peripheral T-cell lymphomas are aggressive diseases. Pralatrexate is an antimetabolite. Hereby, we are reporting a pralatrexate induced durable response in a relapsed/refractory peripheral T-Cell lymphoma patient with a history of autologous stem cell transpl

Keywords:

Autologous stem-cell transplantation
Physical therapy
Medicine
Diabetes mellitus
Oncology
Pralatrexate
Internal medicine
Refractory Peripheral T-cell Lymphoma
Procarbazine
Vincristine
Peripheral T-cell lymphoma
Surgery
Brentuximab vedotin
Transplantation
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations